GeneChem Inc. Receives U.S. FDA NDIN No Objection for Siallac6®, 6'-Sialyllactose Sodium Salt in Collaboration with REJIMUS, INC.
· prweb.com
GeneChem Inc., a biotechnology company specializing in AI-powered enzyme engineering and the development of high-value biomaterials, today announced that the U....
"This FDA acknowledgment is an important step in expanding the Siallac® platform for the U.S. adult dietary supplement market," said Dr. Nam Huh, CEO of GeneCh...